Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.


YOU DECIDE: PATIENTS OR CAREGIVERS ADMINISTER AT HOME OR YOU ADMINISTER IN OFFICE

Dosing regimens based on patient weight with no loading dose1

WEIGHT-TIERED DOSING REGIMEN1

15 to <30 kg

Every 2 weeks

200mga 
1 pre-filled pen or syringe

30 to <40 kg

Every 2 weeks

300mgb 
1 pre-filled pen

≥ 40 kg

Every week

300mgb 
1 pre-filled pen

 

DUPIXENT PRE-FILLED PEN AND PRE-FILLED SYRINGE1

   

Available in 200 mg and 300 mg   
Indicated for patients 2+ years of age

Available in  200 mg 
Indicated for patients 1+ years of age

a 200 mg=1.14 mL solution. 
b 300 mg=2 mL solution.
 

Dosing regimens based on patient weight with no loading dose1

ADMINISTER AT DIFFERENT INJECTION SITES1

  • Administer the subcutaneous injection into the thigh or abdomen, except for the 5cm around the navel
  • The upper arm can also be used if a caregiver administers the injection
  • Rotate the injection site with each injection
  • DO NOT inject DUPIXENT into skin that is tender, damaged, bruised, or scarred

Please see the Patient Information Leaflet for more information on injection.

HOW TO USE DUPIXENT1

  • A patient may self-inject DUPIXENT-or a caregiver may administer DUPIXENT-after training has been provided by a healthcare provider on proper subcutaneous injection technique using the pre-filled syringe or pen
    • In children 12 years of age and older, it is recommended that DUPIXENT be administered under the supervision of an adult
    • In children 1 year to less than 12 years of age, DUPIXENT should be given by a caregiver
  • It is important to provide proper training to patients and/or caregivers on the preparation and administration of DUPIXENT prior to use
  • After administration, advise patients to follow sharps disposal recommendations
  • Patients and/or caregivers should read the appropriate Instructions for Use prior to injecting

Important administration instructions

  • Patients should read the Instructions for Use prior to injecting
  • Instruct patients and/or caregivers to administer the subcutaneous injection into the thigh or abdomen, except for the 2 inches (5 cm) around the navel
  • The upper arm can also be used if a caregiver administers the injection
  • It is important to rotate the injection site with each injection.DO NOT inject DUPIXENT into skin that is tender, damaged, bruised, or scarred
  • If a dose is missed, administer the dose as soon as possible and start a new weekly schedule from the date of the last administered dose

Reference:

  1. DUPIXENT Summary of Product Characteristics, 2026.

Dupixent API

MAT-SA-2600496/v1/September 2026